Development of a recombinant hepatitis B immunoglobulin derived from B cells collected from healthy individuals administered with hepatitis B virus vaccines: A feasibility study.
Transfusion
; 63(6): 1204-1214, 2023 06.
Article
in En
| MEDLINE
| ID: mdl-37119513
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Epstein-Barr Virus Infections
/
Hepatitis B
Limits:
Humans
Language:
En
Journal:
Transfusion
Year:
2023
Document type:
Article
Affiliation country:
Japan
Country of publication:
United States